White Papers

Provided By:

Syneos Health

November 10, 2021

Established Brands – inclusive of both core brands late in their lifecycle and non-core assets in their prime – can represent a significant source of revenue for pharmaceutical companies and still deliver critical and ongoing therapeutic value to patients. This class is ofte … Read More »

Provided By:

Mobiquity

November 3, 2021

Today, we all use a proliferation of channels – including conversational AI platforms like chat and voice. Given the speed of this shift, it’s not surprising that conversational AI is gaining traction in digital marketing, product design, and communication circles. But when … Read More »

Provided By:

PINC AI Applied Sciences

November 2, 2021

A new paradigm is emerging to use real-world evidence from a variety of data sources to supplement randomized clinical trials and support regulatory decision-making for drugs and devices to better understand the patient journey. In this white paper you’ll gain visibility to … Read More »

Provided By:

Avant Healthcare

October 6, 2021

While influencer marketing has been around for as long as there’s been advertising—think Santa Claus and Coca-Cola, Michael Jordan and Nike, Britney Spears and Pepsi—digital influencer marketing is relatively new and has become ubiquitous with the emergence of social media. … Read More »

Provided By:

WCG

September 29, 2021

by Tyler Bye and Patrick McNamara WCG ThreeWire Find out how a Proactive Approach to Site Augmentation Helps Enroll Over 30,000 Vaccine Study Participants in Just Over Three Months. As COVID-19 spread around the world, the accompanying lockdowns and travel restrictions broug … Read More »

Provided By:

Health Advances

September 27, 2021

CRISPR-based gene editing technology is differentiated from other modalities, even traditional gene therapies, unlocking potential cures for a range of indications but also presenting unique developmental challenges. Devising a portfolio strategy for CRISPR-based gene editin … Read More »

Provided By:

Two Labs

September 3, 2021

Medical Science Liaisons (MSLs) are vital to the success of every company. They provide physicians and other healthcare providers with the information and data necessary to ensure that medicines are utilized effectively and safely, they serve as scientific peers and resource … Read More »

Provided By:

WCG IRB

September 1, 2021

Changes in Research (CIRs) come in various forms: protocol amendments, administrative letters, notes to file, safety reports, study committee reports, recruitment plans and unanticipated problems. In this whitepaper we discuss how to assess whether an event meets the guideli … Read More »

Provided By:

Archbow Consulting

August 17, 2021

There is a distinct difference between outstanding patient support programs and less effective programs. A defining characteristic of successful programs is the level of cross-functional collaboration. By following the six strategies in this white paper, pharmaceutical compa … Read More »

Provided By:

Health Advances

July 22, 2021

The development and commercialization of novel biopharmaceutical products in recent years has continued to offer more safe and efficacious treatment options for patients across therapeutic areas. While a good proportion of the world’s transformative drug development and earl … Read More »

Provided By:

S3 Connected Health

June 16, 2021

The type of digital health solutions needed to address the range of challenges faced by pharma companies fall increasingly into the classification of Software as a Medical Device (SaMD). In this whitepaper, experts from S3 Connected Health, Servier, and other leaders in the … Read More »

Provided By:

Bio-Rad

June 2, 2021

Mycoplasma is a common cell culture contaminant. Due to its small size, Mycoplasma cannot be detected by standard light microscopy. In addition, Mycoplasma is gram negative and therefore resistant to beta-lactam antibiotics routinely used in cell culture. When manufacturing … Read More »

Provided By:

WCG

June 1, 2021

Whether the focus is endpoint adjudication, aggregate data monitoring or safety assessment, the clinical and device development industry clearly understands the value of establishing expert scientific committees to provide oversight on study data. These expert committee asse … Read More »

Provided By:

eClinical Solutions

May 25, 2021

As the last year has shown, the life sciences industry has reached a new era in drug discovery, where new medicines can rapidly be brought to market safely and effectively under the right conditions. Clinical data has become one of the most powerful assets for life sciences  … Read More »

Provided By:

WCG

April 26, 2021

Before 2020, most study training provided to clinical research sites relied heavily on monitors doing training at initiation visits, and web-based on-demand training was a novel concept used by only a few forward-thinking sponsors. When the COVID-19 pandemic hit, web-based o … Read More »

Provided By:

WCG IRB

April 12, 2021

Paying participants for the essential role that they play in clinical trials is important, but the amount given, and how it is paid, require careful consideration. Appropriately compensating clinical trial participants lessens the financial burden placed on them by participa … Read More »

Provided By:

TrialCard

April 7, 2021

In less than a week, in the face of a pandemic, the pharmaceutical sales model changed forever. In-person healthcare provider (HCP) visits came to a screeching halt and brand marketers scrambled to find ways to educate and engage these providers remotely. While the pandemic … Read More »

Provided By:

Elligo Health Research

April 6, 2021

If identifying and including patients is one of the biggest hurdles of a clinical trial, how does access to 100 million patients sound? This white paper shares how a robust patient database is one critical key that impacts multiple facets of a trial, leading to more successf … Read More »

Provided By:

Clinical Ink

March 26, 2021

The biggest challenge facing clinical research today is the need to gather, analyze, and report data. To collect patient data more efficiently, the industry has turned to electronic patient-reported outcome (ePRO) tools, which allow patients to enter data themselves, most of … Read More »

Provided By:

TrialCard

December 9, 2020

Since the end of the pharmaceutical industry’s “blockbuster era” and the beginning of its “specialty product era”, drug makers have used the term “hub services” to describe the often ponderous process of  ranting patients access to critical medications. While the term itself … Read More »

Provided By:

ArcheMedX

December 8, 2020

Discover what you can do today to firmly establish your competitive advantage – to avoid being relegated to the sidelines. Will 2021 allow us to bid farewell to COVID-19? Whether we can eradicate this terrible virus or not, many of its impacts will persist. To assist Sponsor … Read More »

Provided By:

WCG

November 9, 2020

Targeted expertise when and where you need it: WCG Clinical Research Coordinators help equip sites to navigate the “new normal.”

Provided By:

TrialCard Incorporated

October 29, 2020

As the market landscape relative to co-pay assistance programs continues to evolve, it is important for biopharmaceutical manufacturers to have a practical strategy in place.  This white paper provides valuable insight into planning for 2021 and beyond. TrialCard Incorporate … Read More »

Provided By:

Avant Healthcare

October 27, 2020

The defining medium of our age, social media has revolutionized the way we communicate, learn about the world, and organize ourselves into communities. For doctors and other HCPs, social media presents an unprecedented opportunity for engagement and collaboration that is sha … Read More »

Provided By:

ArcheMedX

October 8, 2020

A deer in the headlights. That’s an easy way to describe most sales leaders right now, as they formulate how they’re going to implement new “virtual selling” sales frameworks with their formerly “press the flesh” sales teams. But really – a year ago – if you’d suggested to m … Read More »

Provided By:

Elligo Health Research

August 14, 2020

As COVID-19 continues to disrupt clinical research, the consequences are poised to be devastating for sponsors, physicians, patients, and worldwide health. Elligo Health Research® is uniquely situated and experienced to support the continuation of effective clinical research … Read More »

Provided By:

Elligo Health Research

August 10, 2020

The disconnect between clinical research and medical care has become increasingly burdensome, especially in the wake of the COVID-19 pandemic. As clinical research sponsors continually seek ways to accelerate their trials while maintaining safety and quality, technology rema … Read More »

Provided By:

WCG

August 5, 2020

Infectious disease “challenge” studies, in which healthy participants are deliberately infected with pathogens to investigate the cause, prevention, and treatment of infectious diseases, hold great potential for delivering high-quality data about new interventions. Infectiou … Read More »

Provided By:

Clinical Ink

May 28, 2020

Download this free white paper to learn how a BYOD ePRO approach is beneficial to your trial. The biggest challenge facing clinical research today is the need to gather, analyze, and report data. To collect patient data more efficiently, researchers are increasingly explorin … Read More »

Provided By:

TrialCard

March 30, 2020

Affordability programs, like co-pay programs, are highly effective at helping patients initiate therapy by reducing cost barriers. While they also improve fill rates incrementally, affordability programs only address the financial barriers to non-adherence without tackling t … Read More »

Provided By:

81qd

February 26, 2020

Susan  Abedi shares how AI can be a positive disruptor for diagnosis – how to take advantage of  its potential and engage effectively with HCPs and patients to shorten the time to diagnosis. She also covers how AI can raise awareness of the clinical journey. There is also a … Read More »

Provided By:

LexisNexis Risk Solutions

January 31, 2020

The world of medical claims data can be extremely complex. With over 100,000 ICD-10 diagnosis and CPT procedure codes currently in use, to wade through de-identified claims data often rests solely on the expertise of those who can confidently navigate vast amounts of big dat … Read More »

Provided By:

LexisNexis

January 10, 2020

View this informative infographic containing numerous statistics about influenza in the U.S.

Provided By:

Manatt Health

October 15, 2019

To help you manage effectively through the intricacies of 340B, Manatt Health has developed a 50-state survey on 340B, analyzing how states reimburse 340B covered entities and contract pharmacies for 340B drugs, and the steps states are taking to avoid duplicate discounts. D … Read More »

Provided By:

PharmaSeek

August 21, 2018

Over the years, studies have been conducted to ascertain the cost of research and development (“R&D”) required to bring a new drug to market. Experts disagree on the exact amount, but the consensus is that the figure is in the hundreds of millions to over a billion dolla … Read More »

FEEDBACK